- Ticker
- CAPR
- Asset type
- Stocks
- Collections
Healthcare
Biotec
Capricor Therapeutics
Capricor Therapeutics is a clinical-stage biotechnology company focused on developing transformative cell and exosome-based therapies for rare diseases. The firm's lead product candidate, Deramiocel, is an allogeneic cardiac-derived cell therapy currently in Phase 3 clinical trials for the treatment of Duchenne muscular dystrophy. Additionally, the company leverages its proprietary StealthX platform to engineer exosomes for vaccines and targeted delivery of nucleic acids and proteins to treat a broad range of medical conditions.
How to buy Capricor Therapeutics on Grow →
Trading hours
The following are when you can trade Capricor Therapeutics in Grow (24/5).
| Session | Hours (ET) | Tradeable |
|---|---|---|
| Pre-market | 4:00 AM–9:30 AM ET | |
| Regular | 9:30 AM–4:00 PM ET | |
| After-hours | 4:00 PM–8:00 PM ET | |
| Overnight | 8:00 PM–4:00 AM ET (next day) |
Excludes US market holidays.
Capricor Therapeutics is a tokenized asset that is backed 1:1 by the underlying security held at a licensed custodian. Learn more
